Cutera, Inc. (CUTR)

Market Cap	6.12M
Revenue (ttm)	155.21M
Net Income (ttm)	-143.71M
Shares Out	20.26M
EPS (ttm)	-7.17
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	361,346
Open	0.303
Previous Close	0.303
Day's Range	0.281 - 0.308
52-Week Range	0.280 - 4.970
Beta	1.35
Analysts	Hold
Price Target	3.00 (+892.39%)
Earnings Date	Nov 7, 2024

About CUTR

Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device desig...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Mar 31, 2004
• Employees: 430
• Stock Exchange: NASDAQ
• Ticker Symbol: CUTR
• Website: https://www.cutera.com

Financial Performance

In 2023, Cutera's revenue was $212.37 million, a decrease of -15.86% compared to the previous year's $252.40 million. Losses were -$162.83 million, 97.8% more than in 2022.

Analyst Forecast

According to 3 analysts, the average rating for CUTR stock is "Hold." The 12-month stock price forecast is $3.0, which is an increase of 892.39% from the latest price.

Price Target

$3.0

(892.39% upside)

Analyst Consensus: Hold